Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Long-Term Deferred Tax (2018 - 2022)

HealthLynked (HLYK) has disclosed Long-Term Deferred Tax for 4 consecutive years, with $8.8 million as the latest value for Q4 2022.

  • On a quarterly basis, Long-Term Deferred Tax changed N/A to $8.8 million in Q4 2022 year-over-year; TTM through Dec 2022 was $8.8 million, a N/A change, with the full-year FY2022 number at $8.8 million, changed N/A from a year prior.
  • Long-Term Deferred Tax was $8.8 million for Q4 2022 at HealthLynked, up from $4.7 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $8.8 million in Q4 2022 to a low of $1.8 million in Q4 2018.
  • A 4-year average of $4.6 million and a median of $3.8 million in 2019 define the central range for Long-Term Deferred Tax.
  • Peak YoY movement for Long-Term Deferred Tax: soared 62.02% in 2019, then soared 63.03% in 2020.
  • HealthLynked's Long-Term Deferred Tax stood at $1.8 million in 2018, then skyrocketed by 62.02% to $2.9 million in 2019, then skyrocketed by 63.03% to $4.7 million in 2020, then soared by 85.95% to $8.8 million in 2022.
  • Per Business Quant, the three most recent readings for HLYK's Long-Term Deferred Tax are $8.8 million (Q4 2022), $4.7 million (Q4 2020), and $2.9 million (Q4 2019).